Literature DB >> 23241068

Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases.

Kaspars Tars1, Daniela Vullo, Andris Kazaks, Janis Leitans, Alons Lends, Aiga Grandane, Raivis Zalubovskis, Andrea Scozzafava, Claudiu T Supuran.   

Abstract

Coumarins were recently shown to constitute a novel class of mechanism-based carbonic anhydrase (CA, EC 4.2.1.1) inhibitors. We demonstrate that sulfocoumarins (1,2-benzoxathiine 2,2-dioxides) possess a similar mechanism of action, acting as effective CA inhibitors. The sulfocoumarins were hydrolyzed by the esterase CA activity to 2-hydroxyphenyl-vinylsulfonic acids, which thereafter bind to the enzyme in a region rarely occupied by other classes of inhibitors. The X-ray structure of one of these compounds in adduct with a modified CA II enzyme possessing two amino acid residues from the CA IX active site, allowed us to decipher the inhibition mechanism. The sulfonic acid was observed anchored to the zinc-coordinated water molecule, making favorable interactions with Thr200 and Pro201. Some other sulfocoumarins incorporating substituted-1,2,3-triazole moieties were prepared by using click chemistry and showed low nanomolar inhibitory action against the tumor-associated isoforms CA IX and XII, being less effective against the cytosolic CA I and II.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23241068     DOI: 10.1021/jm301625s

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  41 in total

1.  Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.

Authors:  Mark P Thomas; Barry V L Potter
Journal:  J Med Chem       Date:  2015-06-12       Impact factor: 7.446

2.  Continued Structural Exploration of Sulfocoumarin as Selective Inhibitor of Tumor-Associated Human Carbonic Anhydrases IX and XII.

Authors:  Simone Giovannuzzi; Clemente Capasso; Alessio Nocentini; Claudiu T Supuran
Journal:  Molecules       Date:  2022-06-24       Impact factor: 4.927

3.  Potential anticancer activities of Rhus coriaria (sumac) extract against human cancer cell lines.

Authors:  Sami A Gabr; Ahmad H Alghadir
Journal:  Biosci Rep       Date:  2021-05-28       Impact factor: 3.840

Review 4.  Probing the surface of human carbonic anhydrase for clues towards the design of isoform specific inhibitors.

Authors:  Melissa A Pinard; Brian Mahon; Robert McKenna
Journal:  Biomed Res Int       Date:  2015-02-24       Impact factor: 3.411

5.  Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells.

Authors:  Joanna Kopecka; Ivana Campia; Andrea Jacobs; Andreas P Frei; Dario Ghigo; Bernd Wollscheid; Chiara Riganti
Journal:  Oncotarget       Date:  2015-03-30

Review 6.  Non-Classical Inhibition of Carbonic Anhydrase.

Authors:  Carrie L Lomelino; Claudiu T Supuran; Robert McKenna
Journal:  Int J Mol Sci       Date:  2016-07-16       Impact factor: 5.923

Review 7.  Legionella pneumophila Carbonic Anhydrases: Underexplored Antibacterial Drug Targets.

Authors:  Claudiu T Supuran
Journal:  Pathogens       Date:  2016-06-16

8.  An update on anticancer drug development and delivery targeting carbonic anhydrase IX.

Authors:  Justina Kazokaitė; Ashok Aspatwar; Seppo Parkkila; Daumantas Matulis
Journal:  PeerJ       Date:  2017-11-23       Impact factor: 2.984

9.  Azidothymidine "Clicked" into 1,2,3-Triazoles: First Report on Carbonic Anhydrase-Telomerase Dual-Hybrid Inhibitors.

Authors:  Emanuela Berrino; Andrea Angeli; Dmitry D Zhdanov; Anna P Kiryukhina; Andrea Milaneschi; Alessandro De Luca; Murat Bozdag; Simone Carradori; Silvia Selleri; Gianluca Bartolucci; Thomas S Peat; Marta Ferraroni; Claudiu T Supuran; Fabrizio Carta
Journal:  J Med Chem       Date:  2020-06-10       Impact factor: 7.446

Review 10.  Bioactive Natural Product and Superacid Chemistry for Lead Compound Identification: A Case Study of Selective hCA III and L-Type Ca2+ Current Inhibitors for Hypotensive Agent Discovery.

Authors:  Hélène Carreyre; Grégoire Carré; Maurice Ouedraogo; Clarisse Vandebrouck; Jocelyn Bescond; Claudiu T Supuran; Sébastien Thibaudeau
Journal:  Molecules       Date:  2017-05-31       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.